272 related articles for article (PubMed ID: 8022709)
21. Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors.
Von Schrenck T; Heinz-Erian P; Moran T; Mantey SA; Gardner JD; Jensen RT
Am J Physiol; 1989 Apr; 256(4 Pt 1):G747-58. PubMed ID: 2539739
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the murine pancreatic receptor for gastrin releasing peptide and bombesin.
Fanger BO; Wade AC; Cardin AD
Regul Pept; 1991 Feb; 32(3):241-51. PubMed ID: 1650953
[TBL] [Abstract][Full Text] [Related]
23. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
Halmos G; Wittliff JL; Schally AV
Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958
[TBL] [Abstract][Full Text] [Related]
24. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
Markwalder R; Reubi JC
Cancer Res; 1999 Mar; 59(5):1152-9. PubMed ID: 10070977
[TBL] [Abstract][Full Text] [Related]
25. Bombesin receptor in membranes from Swiss 3T3 cells. Binding characteristics, affinity labelling and modulation by guanine nucleotides.
Sinnett-Smith J; Lehmann W; Rozengurt E
Biochem J; 1990 Jan; 265(2):485-93. PubMed ID: 2154190
[TBL] [Abstract][Full Text] [Related]
26. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
[TBL] [Abstract][Full Text] [Related]
27. Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer.
Rogers BE; Rosenfeld ME; Khazaeli MB; Mikheeva G; Stackhouse MA; Liu T; Curiel DT; Buchsbaum DJ
J Nucl Med; 1997 Aug; 38(8):1221-9. PubMed ID: 9255155
[TBL] [Abstract][Full Text] [Related]
28. Gastrin releasing peptide-preferring bombesin binding sites in human lung.
Lach E; Coy DH; Dumont P; Landry Y; Gies JP
Eur J Pharmacol; 1994 Nov; 265(1-2):117-20. PubMed ID: 7883024
[TBL] [Abstract][Full Text] [Related]
29. Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines.
Staley J; Coy DH; Jensen RT; Moody TW
J Mol Neurosci; 1993; 4(1):29-40. PubMed ID: 8391295
[TBL] [Abstract][Full Text] [Related]
30. Characterization of ligand binding and processing by bombesin receptors in an insulin-secreting cell line.
Swope SL; Schonbrunn A
Biochem J; 1987 Nov; 247(3):731-8. PubMed ID: 2827637
[TBL] [Abstract][Full Text] [Related]
31. Bombesin/GRP-preferring and neuromedin B-preferring receptors in the rat urogenital system.
Kilgore WR; Mantyh PW; Mantyh CR; McVey DC; Vigna SR
Neuropeptides; 1993 Jan; 24(1):43-52. PubMed ID: 8381528
[TBL] [Abstract][Full Text] [Related]
32. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
Lantry LE; Cappelletti E; Maddalena ME; Fox JS; Feng W; Chen J; Thomas R; Eaton SM; Bogdan NJ; Arunachalam T; Reubi JC; Raju N; Metcalfe EC; Lattuada L; Linder KE; Swenson RE; Tweedle MF; Nunn AD
J Nucl Med; 2006 Jul; 47(7):1144-52. PubMed ID: 16818949
[TBL] [Abstract][Full Text] [Related]
33. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
[TBL] [Abstract][Full Text] [Related]
34. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
[TBL] [Abstract][Full Text] [Related]
35. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
[TBL] [Abstract][Full Text] [Related]
36. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
Narayan S; Guo YS; Townsend CM; Singh P
Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
[TBL] [Abstract][Full Text] [Related]
37. The binding of bombesin and somatostatin and their analogs to human colon cancers.
Radulovic SS; Milovanovic SR; Cai RZ; Schally AV
Proc Soc Exp Biol Med; 1992 Jul; 200(3):394-401. PubMed ID: 1352046
[TBL] [Abstract][Full Text] [Related]
38. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice.
Jungwirth A; Galvan G; Pinski J; Halmos G; Szepeshazi K; Cai RZ; Groot K; Schally AV
Prostate; 1997 Aug; 32(3):164-72. PubMed ID: 9254895
[TBL] [Abstract][Full Text] [Related]
39. Receptors for GRP/bombesin-like peptides in the rat forebrain.
Wolf SS; Moody TW
Peptides; 1985; 6 Suppl 1():111-4. PubMed ID: 2995940
[TBL] [Abstract][Full Text] [Related]
40. Identification of functional GRP-preferring bombesin receptors on human melanoma cells.
Pansky A; Peng F; Eberhard M; Baselgia L; Siegrist W; Baumann JB; Eberle AN; Beglinger C; Hildebrand P
Eur J Clin Invest; 1997 Jan; 27(1):69-76. PubMed ID: 9041380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
